Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

13.63 -0.98 (-6.71%)
Delayed Quote Updated: 3:15 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 951,131
Open 14.61
Bid (Size) 13.62 (200)
Ask (Size) 13.64 (200)
Prev. Close 14.61
Today's Range 13.61 - 14.68
52wk Range 9.820 - 21.45
Shares Outstanding 103,647,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NovoCure: 3 Key Takeaways for Long-Term Investors ↗
Japan's emergence as a second major market is offsetting headwinds in pancreatic cancer, testing whether geographic diversification can sustain growth. 
Via The Motley Fool
Topics Earnings
News headline image
NovoCure Q3 Earnings Call Highlights ↗
NovoCure (NASDAQ:NVCR) reported third-quarter 2026 net revenue of $193 million, up 16% from a year earlier, as growth in its Optune Gio business and an expanding launch of Optune Lua in Japan helped... 
Via MarketBeat
Topics Earnings

Performance

52-Week Range 36.5% below 52-week high
13.63
9.8252W Low 21.4552W High
1 Week 8.8% below 1-week high
11.851W Low 14.941W High

NovoCure Limited - Ordinary Shares (NVCR) traded between $9.82 and $21.45 over the past 52 weeks and last traded at $13.63, 36.5% below its 52-week high. Over the past week it ranged between $11.85 and $14.94.

Past 12 Months
+4.0%
-10.3%
-15.1%
-17.4%
+3.9%
+13.6%
1W +$0.52
1M -$1.57
3M -$2.42
6M -$2.87
YTD +$0.51
1Y +$1.63

NVCR was +13.6% over the past year, -17.4% over six months, +3.9% year to date, +4.0% in the last week.

12 Months vs Market
NVCR
+13.6%
DIA
+9.6%
SPY
+9.0%
QQQ
+5.2%
IWM
+12.6%

Over the past 12 months NVCR returned +13.6% versus DIA (Dow) +9.6%, SPY (S&P 500) +9.0%, QQQ (Nasdaq 100) +5.2% and IWM (Russell 2000) +12.6%.

Volume & Liquidity 0.66× 3-mo avg
Today 951,131 3-mo avg 1.4M
1W
2.6M
1M
1.9M
3M
1.4M
6M
1.6M
YTD
1.7M
1Y
1.7M

NVCR most recently traded 951,131 shares against a 3-month average daily volume of 1.4M.

More News

Read More
News headline image
NovoCure (NVCR) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Novocure (NASDAQ:NVCR) Q3 Results Beat Estimates as Raised Outlook Lifts Stock ↗
Via Chartmill
Novocure (NASDAQ:NVCR) Rallies 13% on Earnings Beat as High Growth Stock Nears Profitability ↗
Via Chartmill
Topics Earnings
News headline image
Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance
From Novocure
Via Business Wire
News headline image
Novocure to Evaluate Tumor Treating Fields Therapy with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Treat Pancreatic Cancer Through Clinical Trial Collaboration and Supply Agreement
From Novocure
Via Business Wire
News headline image
Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer
From Novocure
Via Business Wire
News headline image
Novocure to Report Third Quarter 2026 Financial Results
From Novocure
Via Business Wire
News headline image
NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even ↗
Via MarketBeat
News headline image
Novocure Announces Upcoming Investor Events
From Novocure
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
News headline image
Transcript: NovoCure Q2 2026 Earnings Conference Call ↗
Via Benzinga
Topics Earnings
News headline image
NovoCure Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Novocure Reports Second Quarter 2026 Financial Results
From Novocure
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
From Pomerantz LLP
Via GlobeNewswire
News headline image
Novocure to Report Second Quarter 2026 Financial Results
From Novocure
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
From Pomerantz LLP
Via GlobeNewswire
News headline image
Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
From Novocure
Via Business Wire
News headline image
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? ↗
Via The Motley Fool

Frequently Asked Questions

Is NovoCure Limited - Ordinary Shares publicly traded?
Yes, NovoCure Limited - Ordinary Shares is publicly traded.
What exchange does NovoCure Limited - Ordinary Shares trade on?
NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NovoCure Limited - Ordinary Shares?
The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market
What is the current price of NovoCure Limited - Ordinary Shares?
The current price of NovoCure Limited - Ordinary Shares is 13.63
When was NovoCure Limited - Ordinary Shares last traded?
The last trade of NovoCure Limited - Ordinary Shares was at 11/05/26 03:15 PM ET
What is the market capitalization of NovoCure Limited - Ordinary Shares?
The market capitalization of NovoCure Limited - Ordinary Shares is 1.41B
How many shares of NovoCure Limited - Ordinary Shares are outstanding?
NovoCure Limited - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.